Male Circumcision

Table of ContentsAcknowledgements ............................................................................................................ iiiExecutive Summary Day 1 .................................................................................................. vExecutive Summary Day 2 .............................................................................................. viiiRationale and Statement of Objectives for Days 1 and 2 ............................................... 11.0 Day 1 ............................................................................................................................. 11.1 Evidence: Epidemiological and Biological Findings .......................................... 21.2 Status of Current Clinical Trials, Including Acceptability Studies .....................61.3 Field Research on Acceptability and Feasibility of Introducing MC Services 81.4 Key Areas of Concern .......................................................................................... 131.5 Breakout Sessions ................................................................................................ 161.5.1 Neonatal and child MC issues .................................................................... 171.5.2 Quality of care, including training, safety regulations,counseling methodologies, etc. .................................................................... 171.5.3 Potential advantages and concerns of private-sector approachesincluding cost issues .................................................................................... 171.5.4 Women’s roles and issues, including relation to FGC advocacyand cervical cancer ...................................................................................... 181.5.5 Integration with other RH services ............................................................. 181.6 “Where do we go from here?” – Key Policy and Implementation Issues ........ 191.7 Summary and Conclusions .................................................................................. 211.8 Final Discussion and Closure of Formal Meeting .............................................. 222.0 Day 2 - Smaller Working Group Meeting ............................................................... 232.1 Informal Panel: “How best to move MC programs forward,and with which populations?” ............................................................................. 23MALE CIRCUMCISION: Current Epidemiological and Field Evidencei